# 18F-FAPI-74 PET/CT findings of an inflammatory branchial cleft cyst mimicking cervical metastasis from carcinoma of unknown primary: A case report

**Authors:** Seiji Oyagi, Tomohiko Yamane, Takuya Yamamoto, Norio Yamamoto, Hara Shigeo, Michio Senda, Masahiro Kikuchi

PMC · DOI: 10.1016/j.radcr.2026.01.064 · 2026-02-13

## TL;DR

A case report shows how 18F-FAPI-74 PET can help distinguish between cancer and benign inflammation in the neck.

## Contribution

Demonstrates a case where 18F-FAPI-74 PET correctly identified a benign cyst, avoiding unnecessary cancer treatment.

## Key findings

- 18F-FAPI-74 PET showed no uptake in tonsillar regions, excluding a primary tumor.
- Histopathology confirmed the lesion was an inflamed branchial cleft cyst, not cancer.
- False-positive cytology was attributed to fibrotic inflammation, not malignancy.

## Abstract

Fibroblast-activation protein inhibitor (FAPI) positron-emission tomography (PET) is emerging as a promising alternative to 18F-fluorodeoxyglucose (FDG) PET for head-and-neck cancer. Herein, we describe the case of a 51-year-old man with a cystic level-II neck mass that was intensely FDG-avid and even more avid on 18F-FAPI-74 PET. FDG-PET was performed as standard imaging modality to search for the primary tumor, while 18F-FAPI-74 PET was conducted as part of a clinical trial to detect potential occult lesions missed by FDG. While cytology suggested metastatic squamous-cell carcinoma and FDG PET revealed asymmetric tonsillar uptake, raising suspicion of an occult oropharyngeal primary tumor, 18F-FAPI-74 PET demonstrated an absence of tracer uptake in Waldeyer’s ring. The patient subsequently underwent ipsilateral palatine-tonsillectomy, lingual-tonsil biopsy, and radical neck dissection. Histopathological examination definitively excluded malignancy, identifying the lesion as an inflamed branchial cleft cyst with marked fibroblast proliferation, and confirmed that both tonsils were benign. Consequently, the preoperative cytology suggesting metastatic squamous cell carcinoma was determined to be a false-positive finding. This case underscores the potential of 18F-FAPI-74 PET to exclude tonsillar primaries in carcinomas of unknown primary origin, while highlighting that fibrotic inflammation can cause false-positive uptake.

## Linked entities

- **Chemicals:** 18F-FAPI-74 (PubChem CID 171390022), 18F-fluorodeoxyglucose (PubChem CID 68614), FDG (PubChem CID 68614)
- **Diseases:** squamous-cell carcinoma (MONDO:0005096)

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}
- **Diseases:** pharyngocervical fistula (MESH:D005402), atopic dermatitis (MESH:D003876), cleft cyst (MESH:D003560), mucosal abnormalities (MESH:D052016), Cervical lymph-node metastasis (MESH:D008207), pulmonary fibrosis (MESH:D011658), nodal metastasis (MESH:D009362), cleft (MESH:D002971), IgG4-related disease (MESH:D000077733), CUP (MESH:D009382), squamous cell carcinoma (MESH:D002294), lesion (MESH:D009059), Cancer (MESH:D009369), Branchial cleft cysts (MESH:D001935), swelling (MESH:D004487), hepatic fibrosis (MESH:D008103), metastatic disease (MESH:D000092182), oropharyngeal primary tumor (MESH:D009959), head and neck cancer (MESH:D006258), inflamed (MESH:C531841), inflammation (MESH:D007249), pain (MESH:D010146), tonsillar carcinoma (MESH:D014067)
- **Chemicals:** eosin (MESH:D004801), 68Ga (MESH:C000615430), 18F-fluorodeoxyglucose (MESH:D019788), 18F-FAPI-74 (-), Hematoxylin (MESH:D006416), Orange G (MESH:C008710), 18F (MESH:C000615276)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925265/full.md

---
Source: https://tomesphere.com/paper/PMC12925265